Page last updated: 2024-08-26

fulvestrant and anisomycin

fulvestrant has been researched along with anisomycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badia, E; Duchesne, MJ; Freiss, G; Pons, M; Rabenoelina, F; Semlali, A1
Li, XP; Liao, EY; Luo, XH; Wang, M; Wang, QP; Xie, H; Yang, L1

Other Studies

2 other study(ies) available for fulvestrant and anisomycin

ArticleYear
Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    International journal of cancer, 2002, Apr-10, Volume: 98, Issue:5

    Topics: Anisomycin; Anti-Bacterial Agents; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, ras; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-raf; Receptors, Estrogen; Recombinant Proteins; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

2002
Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Bone, 2012, Volume: 51, Issue:3

    Topics: Adiponectin; Anisomycin; Coculture Techniques; Enzyme Activation; Estradiol; Female; Fulvestrant; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; MAP Kinase Signaling System; Osteoblasts; Osteogenesis; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; RANK Ligand; Receptors, Estrogen; RNA, Messenger; Time Factors

2012